Howmedica Bipolar Prosthesis
510(k) K855231
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK855231 | Date27 Feb 1986 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- KWY
- Device Class
- Class II
- Regulation
- 21 CFR Part 888.3390
- Advisory Committee
- Orthopedic
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 19 Sep 2026
The Howmedica Bipolar Prosthesis is a Prosthesis, Hip, Hemi-, Femoral, Metal/polymer (product code KWY), designed to replace or augment the femoral head in hip arthroplasty. It features a bipolar design, allowing for articulation between the femoral head and a separate acetabular component, reducing wear on the primary bearing surface. Constructed from metal and polymer materials, it is intended for cemented or uncemented fixation depending on clinical requirements.
This device is supplied as a sterile, single-use implant intended for use in orthopedic surgical settings. It is regulated under FDA 510(k) clearance (K855231, K861105) and classified as Class II with special controls. Storage and handling must comply with standard orthopedic implant protocols to ensure sterility and integrity prior to surgical use. No additional regulatory status beyond the stated FDA clearances is implied.
Other devices from Howmedica Corp.
Questions
AI-generated answers, 19 Sep 2026
What is the primary purpose of the Howmedica Bipolar Prosthesis in hip surgery?
The Howmedica Bipolar Prosthesis is designed to replace or augment the femoral head during hip hemi-arthroplasty. Its bipolar design allows the femoral head to articulate with a separate acetabular component, which helps reduce wear on the primary bearing surface compared to traditional single-component implants. This design is particularly useful in cases where preserving joint motion while minimizing wear is critical.
Is the Howmedica Bipolar Prosthesis intended for cemented or uncemented fixation, and how should it be used?
The prosthesis is engineered for flexibility in surgical technique—it can be used with either cemented or uncemented fixation, depending on the clinical requirements and surgeon preference. The choice between cemented and uncemented fixation is determined by factors such as patient bone quality, age, and overall health, rather than a restriction imposed by the device itself.
How is the Howmedica Bipolar Prosthesis supplied, and what precautions should be taken during storage?
The device is supplied as a sterile, single-use implant, meaning it is intended for one surgical procedure only. To maintain sterility and integrity before use, it must be stored and handled according to standard orthopedic implant protocols. This typically includes keeping the packaging sealed, avoiding contamination, and adhering to manufacturer guidelines for shelf life and environmental conditions.
What materials are used in the construction of the Howmedica Bipolar Prosthesis, and how does this affect its function?
The prosthesis is constructed from metal and polymer materials, combining durability with the ability to articulate smoothly. The metal component provides structural integrity and load-bearing capacity, while the polymer likely contributes to the bearing surface’s wear resistance and smooth articulation between the femoral head and acetabular component, reducing friction and extending the longevity of the implant.
How is the regulatory status of the Howmedica Bipolar Prosthesis determined, and what does this mean for clinicians?
The device holds FDA 510(k) clearance under the product code KWY, classified as Class II with special controls. This means it has undergone a premarket notification process to demonstrate substantial equivalence to a legally marketed predicate device, ensuring it meets applicable safety and performance standards. Clinicians can rely on this clearance as evidence that the prosthesis has been evaluated for its intended use in hip hemi-arthroplasty, though individual surgical decisions should still align with clinical guidelines and patient-specific factors.